Compare CIO & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CIO | PROF |
|---|---|---|
| Founded | 2013 | N/A |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.5M | 199.3M |
| IPO Year | 2014 | N/A |
| Metric | CIO | PROF |
|---|---|---|
| Price | $6.96 | $7.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | ★ 512.7K | 83.9K |
| Earning Date | 02-19-2026 | 11-13-2025 |
| Dividend Yield | ★ 4.32% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $163,795,000.00 | $14,297,000.00 |
| Revenue This Year | $0.32 | $64.23 |
| Revenue Next Year | $3.20 | $113.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.94 |
| 52 Week Low | $4.19 | $3.76 |
| 52 Week High | $7.01 | $7.99 |
| Indicator | CIO | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 61.70 | 66.48 |
| Support Level | $6.94 | $7.19 |
| Resistance Level | $6.97 | $7.91 |
| Average True Range (ATR) | 0.03 | 0.39 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 92.11 | 81.87 |
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.